Translation of Anticancer Efficacy From Nonclinical Models to the Clinic. (6th August 2014)

• Record Type: Journal Article
• Authors: Stroh, M; Duda, DG; Takimoto, CH; Yamazaki, S; Vicini, P
• Is Part Of: CPT: pharmacometrics & systems pharmacology. Volume 3:Number 8(2014)
• Page Start: 1
• Page End: 4
• Publication Date: 2014-08-06
• Subjects: Pharmacokinetics -- Periodicals; Pharmacology -- Periodicals; Pharmacokinetics; Periodicals; 615.05
• DOI: 10.1038/psp.2014.28
• Languages: English
• ISSNs: 2163-8306

Abstract

Abstract : Mouse cancer models have provided critical insights into tumor biology; however, clinical translation of these findings has been challenging. This perspective posits that factors impacting on successful translation start with limitations in capturing human cancer pathophysiology and end with challenges in generating robust translatable preclinical end points. A comprehensive approach that considers clinically relevant mouse models with both an integrated biomarker strategy and a complementary modeling and simulation effort will strengthen the current oncology drug development paradigm. CPT Pharmacometrics Syst. Pharmacol . (2014) 3, e128; doi:10.1038/psp.2014.28 ; published online 06 August 2014